Characterization of CD20 expression loss as a mechanism of resistance to mosunetuzumab in patients with relapsed/refractory B-cell non-Hodgkin lymphomas.
暂无分享,去创建一个
E. Piccione | H. Koeppen | N. Bartlett | M. Wei | S. Schuster | C. Bolen | E. Penuel | M. Matasar | S. Assouline | L. Budde | L. Huw | Deanna G. Wilson | S. Yin